August 5, 2022 PRO Consortium Announces Publication of Open Access Article C-Path’s PRO Consortium announces that “Comparing patient global impression of severity and patient global impression of chang
July 25, 2022 Diary for Irritable Bowel Syndrome Symptoms-Constipation Now Available for Licensing C-Path’s PRO Consortium is pleased to announce that the Diary for Irritable Bowel Syndrome Symptoms–Constipation (DIBSS–C) i
July 15, 2022 eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Administering Complex Cognitive Tests Remotely in The Cognitively-Impair
June 28, 2022 C-Path Welcomes RWS C-Path is proud to welcome RWS as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri
June 28, 2022 C-Path Welcomes Parexel C-Path is proud to welcome Parexel as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri
June 24, 2022 eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Progressing BYOD Adoption” has been published in Applied Clinical Tria
June 8, 2022 PRO Consortium Announces Publication of Open Access Article C-Path’s PRO Consortium is pleased to announce that “Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)
April 2, 2022 eCOA Consortium and PRO Consortium Announce Publication of Open Access Article C-Path’s eCOA Consortium and PRO Consortium are pleased to announce that “Recommendations for the Electronic Migration and
